Sitagliptin Metformin XR Spirig HC 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung

7680691600029 CH-69160 Tabletten mit veränderter Wirkstofffreisetzung

Associated product:

SITAGLIPTINE Metfor XR Spirig HC 50/500mg 160 pce
Sitagliptin Metformin XR Spirig HC 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung
Sitagliptin Metformin XR Spirig HC 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung
Sitagliptin Metformin XR Spirig HC 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung
1 / 3
google

Article details

Package size
160
Selling units
160
Measure
Tablette(n)
Galenic form
Tabletten mit veränderter Wirkstofffreisetzung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/05/2024
Patient information leaflet
Français
16/05/2024
Patient information leaflet
Italien
16/05/2024
Summary of Product Characteristics
Allemand
16/05/2024
Summary of Product Characteristics
Français
16/05/2024
Summary of Product Characteristics
Italien
16/05/2024

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
2.1 MG Substance HBESI

Reimbursement information

Public price
CHF 60.25
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/11/2023

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69160
Drug name
Sitagliptin Metformin XR Spirig HC, Tabletten mit veränderter Wirkstofffreisetzung
Galenic form
TABWF
ATC Code
A10BD07
Authorization status
Z
Dispensing category
B
First authorization
03/08/2023
Authorization expiration date
02/08/2028
IT Number
07.06.2.
Domain
Human medicine
Field of application
Antidiabetikum

Package details

Description (FR)
SITAGLIPTINE Metfor XR Spirig HC 50/500mg 160 pce
Description (DE)
SITAGLIPTIN Metfor XR Spirig HC 50/500mg 160 Stk
Market launch
03/08/2023
Narcotic (BTM)
No

Original drug

Janumet, Filmtabletten
GTIN: 7680584500016
CHF 41.30
View original

Other package sizes (5)

SITAGLIPTINE Metfor XR Spirig HC 50/500mg 60 pce
60 TABL
GTIN: 7680691600012
View
SITAGLIPTINE Metfor XR Spirig HC 50/1000mg 60 pce
60 TABL
GTIN: 7680691600036
View
SITAGLIPTINE Metfor XR Spirig HC 50/1000mg 160 pce
160 TABL
GTIN: 7680691600043
View
SITAGLIPTINE Metfor XR Spirig HC 100/1000mg 30 pce
30 TABL
GTIN: 7680691600050
View
SITAGLIPTINE Metfor XR Spirig HC 100/1000mg 90 pce
90 TABL
GTIN: 7680691600067
View